| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4360 | r78206 | Efficient stabilizer of Mahoney procapsids |
|
| DCC4361 | R93274 | Potent and selective antagonist of 5-HT2A receptors |
|
| DCC4362 | Rac-azd8186 | Novel inhibitor of PI3Kβ and PI3Kδ, inhibiting growth of PTEN deficient breast and prostate tumor |
|
| DCC4363 | Racemetirosine Methyl Ester Hcl | Prodrug of Racemetirosine, an inhibitor of tyrosine 3-monooxygenase |
|
| DCC4364 | Rachelmycin | Novel potent DNA-alkylating agent, inhibiting TBP/DNA interaction |
|
| DCC4365 | Rac-nbi-74330 Featured | rac-NBI-74330 is a potent and selective CXCR3 antagonist. |
|
| DCC4366 | Rac-tofacitinib | Inhibitor of Janus kinases |
|
| DCC4367 | Rad35010 | Novel potent selective androgen receptor modulator (SARM) |
|
| DCC4368 | Radical Scavenger C7 | Potent anti-free radical agent, elevating glutathione peroxidase (GSH-PX) and super oxide dismutase (SOD) levels and lowering malonaldehyde (MDA) level in vivo in the Alzheimer's model |
|
| DCC4369 | Radicicol | Hsp90 N-terminal inhibitor |
|
| DCC4370 | Radotinib Dihydrochloride | Novel inhibitor of the tyrosine kinase BCR-ABL and platelet-derived growth factor receptor, inhibiting mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression |
|
| DCC4371 | Ralimetinib | Novel potent inhibitor of p38 MAPK |
|
| DCC4372 | Ram2061 | Novel inhibitor of geranylgeranyl diphosphate synthase (GGDPS), showing significant reduction in tumor growth in mice |
|
| DCC4373 | Ram2093 | Novel inhibitor of geranylgeranyl diphosphate synthase (GGDPS) |
|
| DCC4374 | Raseglurant | Novel metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator (NAM) |
|
| DCC4375 | R-bc154 | Potent fluorescent α4β1/α9β1 inhibitor |
|
| DCC4376 | Rbm2-1b | Novel dual inhibitor of dihydroceramide desaturase (dhCerDS) and acid ceramidase (ACDase) |
|
| DCC4377 | Rbm2-1d | Novel dual inhibitor of dihydroceramide desaturase (dhCerDS) and acid ceramidase (ACDase) |
|
| DCC4378 | Rbpi-3 | Selective inhibitor of poly(ADP-Ribose) glycohydrolase (PARG) |
|
| DCC4379 | Rc-33 Hydrochloride | Novel highly potent, selective, and metabolically stable σ1 receptor agonist potentiating NGF-induced neurite outgrowth |
|
| DCC4380 | Rdrp Inhibitor 11q | Novel Potent Broad-Spectrum Inhibitor of Influenza A Virus RNA-Dependent RNA Polymerase (RdRp) |
|
| DCC4381 | Rds-1997 | Novel HIV-1 Integrase Inhibitor |
|
| DCC4382 | Rds-2197 | Novel HIV-1 Integrase Inhibitor |
|
| DCC4383 | Recql5-in-4a | Novel potent inhibitor of RECQL5-helicase activity, and stabilizing RECQL5-RAD51 physical interaction, leading to impaired HRR and preferential killing of RECQL5-expressing breast cancer |
|
| DCC4384 | Redoxal | Novel Prenyltransferase Inhibitor with In Vitro and In Vivo Antibacterial Activity |
|
| DCC4385 | Redx03863 | Novel potent inhibitor of the supercoiling and ATPase reactions of DNA gyrase, inhibiting gyrase by preventing the binding of ATP |
|
| DCC4386 | Redx04739 | Novel inhibitor of the supercoiling and ATPase reactions of DNA gyrase, inhibiting gyrase by preventing the binding of ATP and showing selectivity against M. smegmatis. |
|
| DCC4387 | regacin | Novel specific inhibitor of the ability of RegA to activate its target promoters, reducing expression of a number of proteins required for virulence |
|
| DCC4388 | Remeglurant | Novel selective antagonist of the mGlu5 receptor |
|
| DCC4389 | Remifentanil | Potent ultra short-acting synthetic unique opioid analgesic |
|
